Erratum to: Diabetologia

DOI 10.1007/s00125-012-2534-0

In the text box ‘Properties of currently available glucose-lowering agents that may guide treatment choice in individual patients with type 2 diabetes mellitus’ vildagliptin was incorrectly assigned footnote ‘a’ (Limited use in the USA/Europe) instead of footnote ‘b’ (Not licensed in the USA).